Gene regulatory networks

Randall Mayes is a technology futurist, journalist, and author with a Master's from Duke University. He covers topics including AI, neuroscience, and synthetic biology. Experienced in technology and science journalism.

Biotech, drug discovery, gene editing, RNA coverage

Neuromodulation and adaptive behaviour; sonic correspondent

Public television editor with background in newspaper reporting and college advising

Advanced tools in molecular biology research and molecular diagnostics

Reporter specializing in human pluripotent stem cells and skeletal muscle stem/progenitor cell research.

Award-winning science journalist covering biotech, drug discovery, and gene editing based in Boston.

Health, medicine, and science reporting and editorial leadership

Genome editing and engineering including CRISPR/Cas9, TALENs, ZFNs, SynBio

Senior market reporter with extensive experience on Chicago trading floors

Senior editor with 13+ years in publishing, focusing on chemical biology content

Biomedical research and science topics

Economics Editor at Barron's based in New York. Experienced in economic journalism and editorial content. Contributor to a leading financial publication.

Synthetic biology, genetics, neuroscience coverage in top science publications

Legal and regulatory policy content focused on law and governance

Science journalism specializing in neuroscience for online publications

Research and scientific content related to fluorescent reporter proteins

Chromatin immunoprecipitation assays and transcription repression research

Medical economics and healthcare content specializing in editorial roles

Social audio conversations and professional networking content

LA-based producer and reporter focused on US West Coast and Southeast Asia news

Neuroscience and related scientific content editing at Nature Research

Ubiquitin, autophagy, PQC, cell death, membrane biology, Austrian mountains

Neuroscience, medicine, evolution, environment, and technology content

Clinical development and manufacture of large molecule drugs news and analysis

Stories of providers and seekers on biopharma R&D and AI drug marketplaces

Organic agriculture, organic markets, cosmetics, nature, sustainability

Digital media leadership; co-host and creator of multiple shows and podcasts

Biopharma coverage and reporting focused on industry developments

Audio engineering and reporting with youth development focus